mayo clinic glp-1 program On the next episode of Aging Forward from Community Med: GLP-1s have made a big impact on the weight loss industry. But what do we need to consider when using Primary Care in Rochester and

Hohenfellner K, Rauch F, Ariceta G, Awan A, Bacchetta J, Bergmann C, Bechtold S, Cassidy N, Deschenes G, Elenberg E, Gahl WA, Greil O, Harms E, Herzig N, Hoppe B, Koeppl C, Lewis MA, Levtchenko E, Nesterova G, Santos F, Schlingmann KP, Servais A, Soliman NA, Steidle G, Sweeney C, Treikauskas U, Topaloglu R, Tsygin A, Veys K, R VV, Zustin J, Haffner D (2019) Management of bone disease in cystinosis: statement from an international conference

Success will require sustained commitment from multiple stakeholders over many years (Zondervan et al., 2020)

New risks include increased aspiration risk during anesthesia due to delayed gastric emptying and challenges with bowel preparation for colonoscopies [50] [51] [52]

Maintain (Weeks 58): Hold at 50 mcg daily

M., Davison, G

The newer, longer-acting versions like Ozempic and Wegovy were approved more recently (Ozempic in 2017, Wegovy in 2021), but theyve been studied in large clinical trials involving thousands of patients over several years